184 related articles for article (PubMed ID: 18703119)
1. DNA topoisomerase I inhibitors ameliorate seizure-like behaviors and paralysis in a Drosophila model of epilepsy.
Song J; Parker L; Hormozi L; Tanouye MA
Neuroscience; 2008 Oct; 156(3):722-8. PubMed ID: 18703119
[TBL] [Abstract][Full Text] [Related]
2. From bench to drug: human seizure modeling using Drosophila.
Song J; Tanouye MA
Prog Neurobiol; 2008 Feb; 84(2):182-91. PubMed ID: 18063465
[TBL] [Abstract][Full Text] [Related]
3. Seizure suppression by top1 mutations in Drosophila.
Song J; Hu J; Tanouye M
J Neurosci; 2007 Mar; 27(11):2927-37. PubMed ID: 17360915
[TBL] [Abstract][Full Text] [Related]
4. Topoisomerase degradation, DSB repair, p53 and IAPs in cancer cell resistance to camptothecin-like topoisomerase I inhibitors.
Tomicic MT; Kaina B
Biochim Biophys Acta; 2013 Jan; 1835(1):11-27. PubMed ID: 23006513
[TBL] [Abstract][Full Text] [Related]
5. Mutations of the Calcium Channel Gene cacophony Suppress Seizures in Drosophila.
Saras A; Tanouye MA
PLoS Genet; 2016 Jan; 12(1):e1005784. PubMed ID: 26771829
[TBL] [Abstract][Full Text] [Related]
6. Topoisomerase I activity and sensitivity to camptothecin in breast cancer-derived cells: a comparative study.
Tesauro C; Simonsen AK; Andersen MB; Petersen KW; Kristoffersen EL; Algreen L; Hansen NY; Andersen AB; Jakobsen AK; Stougaard M; Gromov P; Knudsen BR; Gromova I
BMC Cancer; 2019 Nov; 19(1):1158. PubMed ID: 31783818
[TBL] [Abstract][Full Text] [Related]
7. Directed evolution to increase camptothecin sensitivity of human DNA topoisomerase I.
Scaldaferro S; Tinelli S; Borgnetto ME; Azzini A; Capranico G
Chem Biol; 2001 Sep; 8(9):871-81. PubMed ID: 11564555
[TBL] [Abstract][Full Text] [Related]
8. Identification and characterization of a deletion mutant of DNA topoisomerase I mRNA in a camptothecin-resistant subline of human colon carcinoma.
Yanase K; Sugimoto Y; Tsukahara S; Oh-Hara T; Andoh T; Tsuruo T
Jpn J Cancer Res; 2000 May; 91(5):551-9. PubMed ID: 10835501
[TBL] [Abstract][Full Text] [Related]
9. Investigation of Seizure-Susceptibility in a
Saras A; Wu VV; Brawer HJ; Tanouye MA
Genetics; 2017 Aug; 206(4):1739-1746. PubMed ID: 28630111
[TBL] [Abstract][Full Text] [Related]
10. Anticonvulsant valproate reduces seizure-susceptibility in mutant Drosophila.
Kuebler D; Tanouye M
Brain Res; 2002 Dec; 958(1):36-42. PubMed ID: 12468028
[TBL] [Abstract][Full Text] [Related]
11. Characterization of a novel topoisomerase I mutation from a camptothecin-resistant human prostate cancer cell line.
Urasaki Y; Laco GS; Pourquier P; Takebayashi Y; Kohlhagen G; Gioffre C; Zhang H; Chatterjee D; Pantazis P; Pommier Y
Cancer Res; 2001 Mar; 61(5):1964-9. PubMed ID: 11280753
[TBL] [Abstract][Full Text] [Related]
12. Mechanical and temperature stressor-induced seizure-and-paralysis behaviors in Drosophila bang-sensitive mutants.
Burg MG; Wu CF
J Neurogenet; 2012 Jun; 26(2):189-97. PubMed ID: 22716921
[TBL] [Abstract][Full Text] [Related]
13. Silatecan DB-67 is a novel DNA topoisomerase I-targeted radiation sensitizer.
Chen AY; Shih SJ; Garriques LN; Rothenberg ML; Hsiao M; Curran DP
Mol Cancer Ther; 2005 Feb; 4(2):317-24. PubMed ID: 15713902
[TBL] [Abstract][Full Text] [Related]
14. Differential induction of topoisomerase I-DNA cleavage complexes by the indenoisoquinoline MJ-III-65 (NSC 706744) and camptothecin: base sequence analysis and activity against camptothecin-resistant topoisomerases I.
Antony S; Jayaraman M; Laco G; Kohlhagen G; Kohn KW; Cushman M; Pommier Y
Cancer Res; 2003 Nov; 63(21):7428-35. PubMed ID: 14612542
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of topoisomerase I cleavage activity by thiol-reactive compounds: importance of vicinal cysteines 504 and 505.
Montaudon D; Palle K; Rivory LP; Robert J; Douat-Casassus C; Quideau S; Bjornsti MA; Pourquier P
J Biol Chem; 2007 May; 282(19):14403-12. PubMed ID: 17355975
[TBL] [Abstract][Full Text] [Related]
16. Human topoisomerase I inhibition: docking camptothecin and derivatives into a structure-based active site model.
Laco GS; Collins JR; Luke BT; Kroth H; Sayer JM; Jerina DM; Pommier Y
Biochemistry; 2002 Feb; 41(5):1428-35. PubMed ID: 11814334
[TBL] [Abstract][Full Text] [Related]
17. Domain interactions affecting human DNA topoisomerase I catalysis and camptothecin sensitivity.
Fiorani P; Amatruda JF; Silvestri A; Butler RH; Bjornsti MA; Benedetti P
Mol Pharmacol; 1999 Dec; 56(6):1105-15. PubMed ID: 10570037
[TBL] [Abstract][Full Text] [Related]
18. Treatment with the antiepileptic drugs phenytoin and gabapentin ameliorates seizure and paralysis of Drosophila bang-sensitive mutants.
Reynolds ER; Stauffer EA; Feeney L; Rojahn E; Jacobs B; McKeever C
J Neurobiol; 2004 Mar; 58(4):503-13. PubMed ID: 14978727
[TBL] [Abstract][Full Text] [Related]
19. Use of camptothecin-resistant mammalian cell lines to evaluate the role of topoisomerase I in the antiproliferative activity of the indolocarbazole, NB-506, and its topoisomerase I binding site.
Urasaki Y; Laco G; Takebayashi Y; Bailly C; Kohlhagen G; Pommier Y
Cancer Res; 2001 Jan; 61(2):504-8. PubMed ID: 11212241
[TBL] [Abstract][Full Text] [Related]
20. Activity of a novel camptothecin analogue, homocamptothecin, in camptothecin-resistant cell lines with topoisomerase I alterations.
Urasaki Y; Takebayashi Y; Pommier Y
Cancer Res; 2000 Dec; 60(23):6577-80. PubMed ID: 11118036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
